Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE.

Daniel J WallaceRoberta Vezza Alexander Tyler O'MalleyArezou KhosroshahiMehrnaz HojjatiKonstantinos LoupasakisJeffrey AlperYvonne SherrerMaria FondalRajesh KatariaTami PowellClaudia IbarraSonali NarainElena MassarottiArthur WeinsteinThierry Dervieux

Published in: Lupus science & medicine (2019)

Our data suggest that MAP/CB-CAPs testing has clinical utility in facilitating SLE diagnosis and treatment decisions.

Keyphrases

systemic lupus erythematosus
clinical trial
study protocol
disease activity
open label
phase iii
phase ii
electronic health record
double blind
high throughput
rheumatoid arthritis
placebo controlled
big data
randomized controlled trial
deep learning
single cell